CRISPR screens for lipid regulators reveal a role for ER-bound SNX13 in lysosomal cholesterol export

J Cell Biol. 2022 Feb 7;221(2):e202105060. doi: 10.1083/jcb.202105060. Epub 2021 Dec 22.

Abstract

We report here two genome-wide CRISPR screens performed to identify genes that, when knocked out, alter levels of lysosomal cholesterol or bis(monoacylglycero)phosphate. In addition, these screens were also performed under conditions of NPC1 inhibition to identify modifiers of NPC1 function in lysosomal cholesterol export. The screens confirm tight coregulation of cholesterol and bis(monoacylglycero)phosphate in cells and reveal an unexpected role for the ER-localized SNX13 protein as a negative regulator of lysosomal cholesterol export and contributor to ER-lysosome membrane contact sites. In the absence of NPC1 function, SNX13 knockdown redistributes lysosomal cholesterol and is accompanied by triacylglycerol-rich lipid droplet accumulation and increased lysosomal bis(monoacylglycero)phosphate. These experiments provide unexpected insight into the regulation of lysosomal lipids and modification of these processes by novel gene products.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport
  • CRISPR-Cas Systems / genetics*
  • Cholesterol / metabolism*
  • Endoplasmic Reticulum / metabolism*
  • Endosomes / metabolism
  • Genetic Testing*
  • Genome
  • Green Fluorescent Proteins / metabolism
  • Humans
  • K562 Cells
  • Lipids / chemistry*
  • Lysosomes / metabolism*
  • Protein Domains
  • Sorting Nexins / chemistry
  • Sorting Nexins / metabolism

Substances

  • Lipids
  • SNX13 protein, human
  • Sorting Nexins
  • Green Fluorescent Proteins
  • Cholesterol